Thanks Bavarian.
Azer-cel is definitely the jewel of Imugene. This is LC's baby and she has rightly said this, esp. last few times. She bought this of Precision and it is her responsibility. Timeline as stated in latest EGM preso, will be FDA meeting late 2025, followed by Phase 2 Registrational studies. Also rightly pointed out by some posters, they will require to pay Precision for this milestone (roughly US$20mn think?). Other trials are Phase 1. They will need to conserve cash and raise some for Azer-cel.
IMHO.
Good luck guys.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.13M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $338.0K | 30.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 3480808 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 10994115 | 28 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |